Interferon-alpha inhibits adipogenesis via regulation of JAK/STAT1 signaling

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 11, 2016, Pages 2416-2427

  Lee, Kyoungran ^a   Um, Sung Hee ^b   Rhee, Dong Kwon ^a   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adipogenesis; IFN ; JAK; STAT1

Indexed keywords

ALPHA INTERFERON; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN DEPENDENT KINASE 2; JANUS KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN P21; SMALL INTERFERING RNA; STAT1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING; 3T3 CELL LINE; ADIPOCYTE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL CYCLE; CYTOLOGY; DRUG EFFECTS; EMBRYONIC STEM CELL; METABOLISM;

3T3 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL CYCLE; CELLS, CULTURED; EMBRYONIC STEM CELLS; HUMANS; INTERFERON-ALPHA; JANUS KINASES; MICE; MICE, INBRED C57BL; PPAR GAMMA; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84979243559     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2016.07.009     Document Type: Article

References (49)

1. [1] Gregoire, F.M., Smas, C.M., Sul, H.S., Understanding adipocyte differentiation. Physiol. Rev. 78 (1998), 783–809.
2. [2] Virtue, S., Vidal-Puig, A., It's not how fat you are, it's what you do with it that counts. PLoS Biol. 6 (2008), 1819–1823.
3. [3] Virtue, S., Vidal-Puig, A., Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1801 (2010), 338–349.
4. [4] Gustafson, B., Gogg, S., Hedjazifar, S., Jenndahl, L., Hammarstedt, A., Smith, U., Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am. J. Physiol. Endocrinol. Metab. 297 (2009), E999–E1003.
5. [5] Arner, P., Arner, E., Hammarstedt, A., Smith, U., Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS One 6 (2011), 1–5.
6. [6] Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, A.W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest., 112, 2003, 1796.
7. [7] Kim, S., Moustaid-Moussa, N., Secretory, endocrine and autocrine/paracrine function of the adipocyte. J. Nutr. 130 (2000), 3110–3115.
8. [8] Uysal, K.T., Wiesbrock, S.M., Marino, M.W., Hotamisligil, G.S., Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389 (1997), 610–614.
9. [9] Adamczak, M., Wiecek, A., The Adipose Tissue as an Endocrine Organ, Seminars in Nephrology. 2013, Elsevier, 2–13.
10. [10] Unger, R.H., Lipotoxic diseases. Annu. Rev. Med. 53 (2002), 319–336.
11. [11] Unger, R.H., Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44 (1995), 863–870.
12. [12] Gustafson, B., Smith, U., Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J. Biol. Chem. 281 (2006), 9507–9516.
13. [13] McArdle, M.A., Finucane, O.M., Connaughton, R.M., McMorrow, A.M., Roche, H.M., Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front. Endocrinol. (Lausanne) 4 (2013), 1–23.
14. [14] González-Navajas, J.M., Lee, J., David, M., Raz, E., Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12 (2012), 125–135.
15. [15] Vidal, C., Bermeo, S., Li, W., Huang, D., Kremer, R., Duque, G., Interferon gamma inhibits adipogenesis in vitro and prevents marrow fat infiltration in oophorectomized mice. Stem Cells 30 (2012), 1042–1048.
16. [16] Ying, W., Kanameni, S., Chang, C.-A., Nair, V., Safe, S., Bazer, F.W., Zhou, B., Interferon tau alleviates obesity-induced adipose tissue inflammation and insulin resistance by regulating macrophage polarization. PLoS One 9 (2014), 1–5, 98835.
17. [17] Birk, R.Z., Rubinstein, M., IFN-α induces apoptosis of adipose tissue cells. Biochem. Biophys. Res. Commun. 345 (2006), 669–674.
18. [18] Goodbourn, S., Didcock, L., Randall, R., Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81 (2000), 2341–2364.
19. [19] Isaacs, A., Lindenmann, J., Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147 (1957), 258–267.
20. [20] Strander, H., Interferon treatment of human neoplasia. Adv. Cancer Res. 46 (1986), 1–265.
21. [21] Scott, G., Tyrrell, D., Antiviral effects of interferon in man. Interferon 4 (1985), 181–215.
22. [22] Ferrantini, M., Capone, I., Belardelli, F., Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89 (2007), 884–893.
23. [23] Koivisto, V.A., Pelkonen, R., Cantell, K., Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 38 (1989), 641–647.
24. [24] Hamamoto, S., Uchida, Y., Wada, T., Moritani, M., Sato, S., Hamamoto, N., Ishihara, S., Watanabe, M., Kinoshita, Y., Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy. J. Gastroenterol. Hepatol. 20 (2005), 204–208.
25. [25] Doerrler, W., Feingold, K.R., Grunfeld, C., Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 6 (1994), 478–484.
26. [26] Hardardottir, I., Doerrler, W., Feingold, K.R., Grunfeld, C., Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. Biochem. Biophys. Res. Commun. 186 (1992), 237–243.
27. [27] Kim, S.-J., Choi, Y., Choi, Y.-H., Park, T., Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J. Nutr. Biochem. 23 (2012), 113–122.
28. [28] Ailhaud, G., Hauner, H., Bray, A., Handbook of Obesity: Etiology and Pathophysiology. 2004.
29. [29] Lee, Y.J., Han, J.Y., Lee, C.G., Heo, K., Park, S.I., Park, Y.S., Kim, J.S., Yang, K.M., Lee, K.-J., Kim, T.-H., Korean Red Ginseng saponin fraction modulates radiation effects on lipopolysaccharide-stimulated nitric oxide production in RAW264. 7 macrophage cells. J. Ginseng Res. 38 (2014), 208–214.
30. [30] Ntambi, J.M., Young-Cheul, K., Adipocyte differentiation and gene expression. J. Nutr. 130 (2000), 3122–3126.
31. [31] Tang, Q.-Q., Otto, T.C., Lane, M.D., Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. 100 (2003), 44–49.
32. [32] Stephens, J.M., Lumpkin, S.J., Fishman, J.B., Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-γ in adipocytes. J. Biol. Chem. 273 (1998), 31408–31416.
33. [33] Murray, P.J., The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178 (2007), 2623–2629.
34. [34] Dimco, G., Knight, R.A., Latchman, D.S., Stephanou, A., STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest. Cell Cycle 9 (2010), 4638–4649.
35. [35] Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
36. [36] Ruan, H., Hacohen, N., Golub, T.R., Van Parijs, L., Lodish, H.F., Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes nuclear factor-κB activation by TNF-α is obligatory. Diabetes 51 (2002), 1319–1336.
37. [37] Kim, S., Jin, Y., Choi, Y., Park, T., Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem. Pharmacol. 81 (2011), 1343–1351.
38. [38] Kolaczynski, J., Taskinen, M.R., Hilden, H., Kiviluoto, T., Cantell, K., Koivisto, V., Effects of interferon alpha on insulin binding and glucose transport in human adipocytes. Eur. J. Clin. Investig. 22 (1992), 292–299.
39. [39] Cornelius, P., MacDougald, O.A., Lane, M.D., Regulation of adipocyte development. Annu. Rev. Nutr. 14 (1994), 99–129.
40. [40] Wessely, R., Interference by interferons: Janus faces in vascular proliferative diseases. Cardiovasc. Res. 66 (2005), 433–443.
41. [41] Levy, D.E., Darnell, J., Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3 (2002), 651–662.
42. [42] Annamalai, D., Clipstone, N.A., Prostaglandin F2α inhibits adipogenesis via an autocrine-mediated interleukin-11/glycoprotein 130/STAT1-dependent signaling Cascade. J. Cell. Biochem. 115 (2014), 1308–1321.
43. [43] Tenney, R., Stansfield, K., Pekala, P.H., Interleukin 11 signaling in 3T3-L1 adipocytes. J. Cell. Physiol. 202 (2005), 160–166.
44. [44] McGillicuddy, F.C., Chiquoine, E.H., Hinkle, C.C., Kim, R.J., Shah, R., Roche, H.M., Smyth, E.M., Reilly, M.P., Interferon γ attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 284 (2009), 31936–31944.
45. [45] Wada, T., Hoshino, M., Kimura, Y., Ojima, M., Nakano, T., Koya, D., Tsuneki, H., Sasaoka, T., Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 300 (2011), 1112–1123.
46. [46] Hogan, J.C., Stephens, J.M., The identification and characterization of a STAT 1 binding site in the PPARγ2 promoter. Biochem. Biophys. Res. Commun. 287 (2001), 484–492.
47. [47] Lefterova, M.I., Lazar, M.A., New developments in adipogenesis. Trends Endocrinol. Metab. 20 (2009), 107–114.
48. [48] Zhao, P., Stephens, J.M., Identification of STAT Target Genes in Adipocytes. JAK-STAT, 2, 2013, 1–7, 23092.
49. [49] Aouadi, M., Laurent, K., Prot, M., Le Marchand-Brustel, Y., Binétruy, B., Bost, F., Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55 (2006), 281–289.